Kyle Sandilands shocks fans with weight loss update following health scare: 'I'm actually quite impressed'
The radio king, 54, who is on a health kick after his shock brain aneurysm announcement, addressed his progress on KIIS FM's The Kyle & Jackie O Show on Thursday after a week of exercise and dieting.
In the radio segment, Jackie, 50, reminded listeners of Kyle's goal to take 'baby steps' in order to inspire others who are struggling with their weight, a program which has been dubbed 'Kyle's Big Fatso Club' by the hosts.
'Fatso Club started a week ago. Your whole initiative with this was to give people baby steps and make it doable for the big fatsos,' she began.
'Your original weigh-in weight last week was 139.7 kilos,' she said, before revealing that Kyle would get on the scale to record his progress a week into his lifestyle transformation.
'Even if I've not lost anything, I'm still going to continue,' he confessed, before hopping onto the scale.
The result prompted an audible gasp from Jackie, who revealed that Kyle weighed in at 137.3 kilograms.
'You've lost over two kilos in one week!' she added, which was met with applause from the studio.
'I'm actually quite impressed with myself,' Kyle replied, chuffed with his progress.
Jackie added: 'Be impressed because it's impressive.'
Kyle's recent health kick comes after he made a heartbreaking admission about the state of his well-being last month.
The radio shock jock revealed on-air that his physical activities were limited due to his 138kg weight, which is 12kg more than he weighed last year.
'I'm 138, I thought I was massive. I've been a bit... I don't know whether "depressed" is the word? Ever since this aneurysm thing came up a year ago,' Kyle told listeners.
'I brushed it off inside. My wife is on me about it, asking if I would like to come for a walk with her and [their son] Otto. I would like to, but just too fat and lazy to go!'
Kyle also mentioned a recent hospital visit for a check-up, noting that he would consider forming a support group for others struggling with weight issues.
'I did all these scans yesterday, haven't got the results yet. If I'm good, then I will put together a club, "Kyle's Big Fatso Club", where I want others to join me in my slow march to healthiness. Who is with me?' he said.
In February, the media personality revealed to listeners he had been diagnosed with a brain aneurysm, which prompted fans of the radio star to express their support.
'On Friday, I was told by my medical team - which sounds like I'm already very sick, that I have a brain aneurysm. It requires immediate attention, brain surgery,' he said at the time.
'My doctor said if I didn't get it checked, I would have died. A life of cocaine abuse and partying are not the way to go!'
He revealed his doctor had banned him from doing cocaine, masturbating, heavy lifting and becoming stressed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
12 minutes ago
- The Independent
Patients warned not to turn to fake weight loss jabs after UK Mounjaro price hike
Medical experts have warned Britons not to turn to fake weight loss jabs after fears the Mounjaro price hike could make it unaffordable for people 'already struggling to pay for it'. The cost of the drug, dubbed the 'King Kong' of weight loss medicine, is set to triple in the UK after its US -owned company equalised costs in markets across the globe. A month's supply of the highest doses of the jab will rise from £122 to £330 - an increase of 170 per cent. Though this will not affect patients prescribed the jab on the NHS, it will affect thousands of people who are currently buying the medicine privately. Professor Claire Anderson, president of the Royal Pharmacist Society (RPS), said the price hike risks rendering the jabs out of reach for people already struggling to afford them. 'It's reassuring that NHS patients with obesity and type 2 diabetes will continue to access Mounjaro,' she told The Independent. 'However, rising private prescription costs may make Mounjaro unaffordable for people in deprived areas already struggling to pay for it.' She said the RPS urges anyone considering obtaining Mounjaro to do so only from a UK pharmacy that is registered with the General Pharmaceutical Council and with a valid prescription. She warned fakes could be harmful or non-effective and said: 'Counterfeit medicines from unregulated sources pose serious health risks—they can contain incorrect doses, harmful substances or no active ingredient at all.' She added that if patients If buying online, check the site displays the official green GPhC logo linking to the GPhC register. Professor Kamila Hawthorne, Chair of the Royal College of GPs, also urged patients to only use reputable outlets and to speak with their private provider if they are concerned about potential price increases to the drug. She said: 'If they are accessing medication through dubious online sources, or without a prescription, it can be a genuine threat to a patient's safety. In some cases, people may not be buying what they think they are, which is really dangerous.' Fake jabs for sale in the UK are already a huge concern, with thousands of fraudulent online pharmacies selling such products having been uncovered. Fake versions of Ozempic, another popular brand of weight loss jab, have been found being sold for as little as £13.70 per dose, along with counterfeit versions of other brands, including Rybelsus and Metformin pills, being offered from 24p. Researchers from Avast, a cybersecurity brand of the company Gen, who conducted the investigation, warned of the 'dangerous' threat of the global scam involving more than 5,000 fake pharmacy sites this year, which they say are being run by criminal networks. It comes amid the rapid rise of weight-loss medication in the UK – with around 1.5 million people, 4 per cent of households, currently using them. These weight-loss injections, also known as GLP-1 receptor agonists, work by mimicking the natural hormone which regulates blood sugar, appetite and digestion. In June, the NHS offered Mounjaro to obese patients with a BMI of over 40 and at least four clinical conditions related to their weight, such as heart disease or type 2 diabetes. Over the next three years, about 240,000 patients are expected to be eligible for the treatment. Mounjaro's owner Eli Lily said it would not raise the price paid by the NHS, and it was working with private healthcare providers to maintain access to the jab. The move reflects how the pharmaceutical industry is navigating policy changes in the US, by far its most lucrative market.
The Sun
42 minutes ago
- The Sun
Rival fat jab WON'T increase in price, makers pledge – as Mounjaro set to double in costs
MAKERS of the fat jab Wegovy say they will not increase the price of the drug when the cost of rival Mounjaro doubles next month. A price war now looms as Danish firm Novo Nordisk said it is committed to keeping its weight loss injection affordable. Slimmers suffered a hammer blow on Thursday when Mounjaro maker Eli Lilly & Co revealed it would ramp up its pharmacy charges in September. Rates first revealed by The Sun show the UK wholesale price for a month's supply of the popular 5mg dose of tirzepatide will double from £92 to £180. A prescription with private pharmacy mark-ups typically costs buyers £150 to £200 and could now surge to more than £300. The minimum 2.5mg dose will cost pharmacies £133 up from £92, with a 10mg dose rising from £107 to £255 and the maximum 15mg from £122 to £330. Patients and pharmacists were shocked by the news and warned it could drive users to the black market. Price war could shake up market Wegovy is thought to be the second most popular weight loss injection used in the UK. It could now see a boom in users as its price will become more competitive after Mounjaro's rise. Studies suggest the jab, known as semaglutide and the same as Ozempic, is not as strong as Mounjaro but is still super-effective. Wegovy currently costs between £100 and £200 per month from private online pharmacies. A Novo Nordisk spokesperson told The Sun: 'We currently have no plans of changing our offering in the UK. 'Our focus is on supporting patients, and we are committed to ensuring that our medicines are not only innovative but also accessible and affordable for those who need them most. 'Our mission is to help create a healthier world by addressing some of the most pressing threats to public health – including obesity, diabetes, and cardiovascular disease.' Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
The Independent
an hour ago
- The Independent
Rare ‘brain-eating amoeba' detected in drinking water supplies in Australia
One of the world's most dangerous water-borne microorganisms, commonly called a 'brain-eating amoeba ', has recently been detected in two drinking water supplies in south-west Queensland. Both affected towns are about 750 kilometres west of Brisbane: Augathella (population roughly 300) and Charleville (population 3,000). During an analysis of water samples commissioned by Queensland Health, Naegleria fowleri was detected in the water systems of two health facilities, one in Charleville and one in Augathella, as well as in the incoming town water supply at both facilities. The Shire Council of Murweh, which takes in the two affected locations, issued a health notice for residents and visitors on August 7, warning of the detection of N. fowleri in the water supplies. So what is this organism? And how significant is the risk likely to be in these Queensland towns, and elsewhere? It's rare – but nearly always fatal The N. fowleri amoeba is a microscopic organism found around the world. It only lives in warm freshwater, generally between 25 and 40°C. This can include ponds, lakes, rivers, streams and hot springs. If someone is infected with N. fowleri, it causes what's called primary amoebic meningoencephalitis, a serious infection of the brain. Symptoms include a sore throat, headache, hallucinations, confusion, vomiting, fever, neck stiffness, changes to taste and smell, and seizures. The incubation period of primary amoebic meningoencephalitis – the time between infection and symptoms appearing – typically ranges from three to seven days. Tragically, this illness is nearly always fatal, even if someone receives medical attention quickly. Death typically occurs about five days after symptoms begin. Fortunately, though, cases are very rare. In the United States, there were 167 reported cases of primary amoebic meningoencephalitis between 1962 and 2024, according to the Centers for Disease Control and Prevention. Only four survived. A global review of the disease up to 2018 reported that, of 381 known cases, Australia accounted for 22, the fifth highest number, after the US, Pakistan, Mexico and India. Some 92% of people died. So how does someone get infected? The route of infection is very unusual and quite specific. N. fowleri infects the brain through a person's nose. The amoeba then passes through a protective membrane called the nasal epithelium. This is an important physical barrier and allows the amoeba to travel to the brain through the olfactory nerve, which is responsible for our sense of smell. The infection then kills brain tissue and causes swelling of the brain, termed cerebral oedema. Infections occur in people when infected water travels up their nose. Most cases involve children and young people who have swum in infected waters. The majority of cases occur in males, with an average age of 14. Even water sports in affected waterways can be dangerous. A person is currently in intensive care in Missouri after it's believed they became infected while water skiing. Regarding the recent detection in Queensland water supply systems, the source of the infection has not been reported. It's possible a fresh waterway, or groundwater, which feeds into the affected drinking water systems, was contaminated with N. fowleri, and the amoeba travelled from there. But this will likely be determined with further investigation. How dangerous is N. fowleri in drinking water? First, it's important to note you can't get primary amoebic meningoencephalitis from drinking contaminated water. But any activity that allows infected water to enter a person's nose is potentially dangerous. This can happen during a bath or a shower. Some people flush their nasal passages to clear congestion related to allergies or a viral infection. This has been linked to infections with N. fowleri. If you're going to flush your nasal passages, you should use a sterile saline solution. Even young children playing with hoses, sprinklers or water activities could be at risk. A 16-month-old child was fatally infected following an incident involving a contaminated water 'splash pad' in the US in 2023. Splash pads are water-based recreation activities, primarily for young children, that involve splashing or spraying water. So what's the risk in Queensland? Regarding N. fowleri, Australian drinking water guidelines advise: If the organism is detected, advice should be sought from the relevant health authority or drinking water regulator. The guidelines also provide recommendations on how to disinfect water supplies and control N. fowleri, using chlorine and other chemical compounds. All public town water supplies across Australia are regularly tested to ensure that the water is safe to drink. We don't yet know the exact cause of the detection of the amoeba N. fowleri in these Queensland towns' water supplies. But drinking or cooking with water contaminated with this amoeba will not cause an infection. Any activity that allows potentially contaminated water to go up the nose should be navigated carefully for now in the affected areas. Contamination of a town's drinking water supply from this amoeba is very rare and is unlikely in other Australian town water supplies. How about swimming? To reduce your risk in potentially infected warm, fresh waters, you should keep your head above water while swimming. And don't jump or dive in. You can use a nose-clip if you want to swim with your head under water. The amoeba cannot survive in salt water, so there's no risk of swimming in the ocean. Also, properly maintained swimming pools should be safe from the organism. New South Wales Health advises that the amoeba cannot survive in water that is clean, cool and adequately chlorinated. Ian A. Wright is an Associate Professor in Environmental Science at Western Sydney University.
